Press Releases

· Hansoh’s HS-20089 complements GSK’s portfolio of gynaecologic cancer therapies        20 October 2023, London UK，GSK plc (LSE/NYSE: GSK) and Hansoh ...

The 24th WIPO-CNIPA Awards for Chinese Outstanding Patented Inventions was held in Dalian in Northeast China on October 14. Hansoh Pharma's Ameile pat...

Recently Chinese leading human resource media company HRoot announced its "2023 HRoot Awards in Greater China". Hansoh Pharma was once again honored w...

The IASLC 2023 World Conference on Lung Cancer (WCLC) is scheduled to be held in Singapore from September 9 - 12, 2023. During this conference, Hansoh...

Recently, the China National Intellectual Property Administration issued its Decision on the Awarding of the 24th China Patent Award. The invention pa...

Shanghai ,July 20, 2023 – Hansoh Pharma(03692.HK）, a leading innovation-driven pharmaceutical company in Greater China, today announced that China’s N...

On June 30, Hansoh Pharma's Saint Luolai(Pegmolesatide Injection) ,the global unique once-monthly peptide-based highly specific EPO receptor activator...

Recently, Hansoh Pharma was included in the first “Sustainability Yearbook (China)” published by S&P Global, ranking in the Top 1% for its S&P Global ...